MIDDLE EAST PHARMACEUTICAL INDUSTRIES TADAWUL:4016:
FY NET PROFIT 97.01 MILLION RIYALS
FY SALES 460.48 MILLION RIYALS
Avalon Pharma FY Profit 97.01 Mln Riyals
Middle East Pharmaceutical Industries Company on 6ix
Earlier from Middle East Pharmaceutical Industries
- Avalon Pharma Contract Sign Off With Bio-Thera Solutions
- Avalon Pharma Grants Three Bonus Shares For Every Four Shares Held
- Avalon Pharma Signs Non-Binding Memorandum Of Understanding With Benta Sas
- Avalon Pharma Q3 Profit SAR 8.28 Mln
- ZAWYA: Saudi's Avalon Pharma renews $14mln credit with Saudi Investment Bank
Later from Middle East Pharmaceutical Industries
- Avalon Pharma H2 Dividend Per Share SAR 1.32
- Avalon Pharma Appoints Ahmad Shaher Al Tabbaa As Chairman
- Avalon Pharma Q1 Profit SAR 26.9 Million
Follow Middle East Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Middle East Pharmaceutical Industries